Peijia Medical Announces Successful Completion of Patient Enrollment for Pivotal TaurusTrio™ Transcatheter Aortic Regurgitation Clinical Trial : vimarsana.com

Peijia Medical Announces Successful Completion of Patient Enrollment for Pivotal TaurusTrio™ Transcatheter Aortic Regurgitation Clinical Trial

SUZHOU, China, Jan. 29, 2024 /PRNewswire/ -- Peijia Medical Limited (Peijia, (9996.HK)), a leading Chinese domestic player in the high-growth transcatheter

Related Keywords

China , Suzhou , Jiangsu , Peijia , Henan , Chinese , John Kilcoyne , Michael Zhang , Peijia Medical Limited , Jenavalve Technology Inc , National Medical Products Administration , Aortic Valve Replacement , Valve System , Aortic Regurgitation , Jenavalve Technology , Greater China , Chief Executive Officer , Late Breaking Clinical Trial , Cardiovascular Therapeutics , Annual Scientific Symposium ,